Download Excel file
Global
Investors
Segment Data and Regional Results
BASF Report 2023
Segment data — Chemicals
-
1
Million € |
2023 | 2022 | +/- |
| Sales to third parties | 10,369 | 14,895 | –30.4% |
of which Petrochemicals |
7,418 | 10,546 | –29.7% |
Intermediates |
2,951 | 4,349 | –32.2% |
Intersegment transfers |
3,606 | 4,860 | –25.8% |
| Sales including transfers | 13,975 | 19,754 | –29.3% |
| Income from operations before depreciation, amortization and special items | 1,167 | 2,774 | –57.9% |
| Income from operations before depreciation and amortization (EBITDA) | 1,167 | 2,771 | –57.9% |
| EBITDA margin before special items (%) | 11.3 | 18.6 | − |
| Depreciation and amortizationa | 803 | 1,013 | –20.8% |
| Income from operations (EBIT) | 364 | 1,758 | –79.3% |
| Special items | 4 | –198 | . |
| EBIT before special items | 361 | 1,956 | –81.6% |
| Investments including acquisitionsb | 2,706 | 1,701 | 59.1% |
| Segment cash flow | –936 | 1,878 | . |
| Assets | 11,468 | 10,481 | 9.4% |
| Return on capital employed (ROCE, %) | 3.3 | 15.6 | − |
| Research and development expenses | 83 | 93 | –10.4% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Materials
Million € |
2023 | 2022 | +/- |
| Sales to third parties | 14,149 | 18,443 | –23.3% |
of which Performance Materials |
7,244 | 8,567 | –15.4% |
Monomers |
6,905 | 9,877 | –30.1% |
| Intersegment transfers | 864 | 1,742 | –50.4% |
| Sales including transfers | 15,013 | 20,186 | –25.6% |
| Income from operations before depreciation, amortization and special items | 1,650 | 2,686 | –38.6% |
| Income from operations before depreciation and amortization (EBITDA) | 1,523 | 2,660 | –42.7% |
| EBITDA margin before special items (%) | 11.7 | 14.6 | − |
| Depreciation and amortizationa | 1,146 | 884 | 29.6% |
| Income from operations (EBIT) | 378 | 1,776 | –78.7% |
| Special items | –449 | –63 | –608.6% |
| EBIT before special items | 826 | 1,840 | –55.1% |
| Investments including acquisitionsb | 1,083 | 880 | 23.1% |
| Segment cash flow | 1,369 | 2,363 | –42.1% |
| Assets | 9,716 | 10,864 | –10.6% |
| Return on capital employed (ROCE, %) | 3.6 | 14.9 | − |
| Research and development expenses | 185 | 201 | –7.7% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Industrial Solutions
Million € |
2023 | 2022 | +/- |
| Sales to third parties | 8,010 | 9,992 | –19.8% |
of which Dispersions & Resins |
4,921 | 6,019 | –18.2% |
Performance Chemicals |
3,088 | 3,973 | –22.3% |
| Intersegment transfers | 436 | 507 | –14.0% |
| Sales including transfers | 8,445 | 10,499 | –19.6% |
| Income from operations before depreciation, amortization and special items | 965 | 1,437 | –32.8% |
| Income from operations before depreciation and amortization (EBITDA) | 1,010
|
1,443 | –30.0% |
| EBITDA margin before special items (%) | 12,0 | 14.4 | − |
| Depreciation and amortizationa | 349 | 346 | 0.9% |
| Income from operations (EBIT) | 660 | 1,097 | –39.8% |
| Special items | 35 | 6 | 480.4% |
| EBIT before special items | 625 | 1,091 | –42.7% |
| Investments including acquisitionsb | 285 | 322 | –11.5% |
| Segment cash flow | 1,292 | 852 | 51.6% |
| Assets | 5,576 | 6,318 | –11.7% |
| Return on capital employed (ROCE, %) | 11.0 | 16.0 | − |
| Research and development expenses | 150 | 172 | –13.0% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Surface Technologies
Million € |
2023 | 2022 | +/- |
| Sales to third parties | 16,204 | 21,283 | -23.9% |
of which Catalysts |
11,818 | 17,062 | -30.7% |
Coatings |
4,387 | 4,220 | 3.9% |
| Intersegment transfers | 176 | 198 | -10.9% |
| Sales including transfers | 16,381 | 21,481 | -23.7% |
| Income from operations before depreciation, amortization and special items | 1,520 | 1,464 | 3.8% |
| Income from operations before depreciation and amortization (EBITDA) | 1,351 | 1,264 | 6.9% |
| EBITDA margin before special items (%) | 9.4 | 6.9 | − |
| Depreciation and amortizationa | 986 | 651 | 51.3% |
| Income from operations (EBIT) | 366 | 612 | -40.3% |
| Special items | –572 | –290 | -97.6% |
| EBIT before special items | 938 | 902 | 4.0% |
| Investments including acquisitionsb | 621 | 740 | -16.2% |
| Segment cash flow | 1,488 | 61 | . |
| Assets | 12,657 | 14,899 | -15.0% |
| Return on Capital Employed (ROCE, %) | 2.7 | 3.9 | − |
| Research and development expenses | 304 | 335 | -9.1% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Nutrition & Care
Million € |
2023 | 2022 | +/- |
| Sales to third parties | 6,858 | 8,066 | -15.0% |
of which Care Chemicals |
4,721 | 5,619 | -16.0% |
Nutrition & Health |
2,137 | 2,447 | -12.7% |
| Intersegment transfers | 429 | 588 | -27.1% |
| Sales including transfers | 7,286 | 8,654 | -15.8% |
| Income from operations before depreciation, amortization and special items | 565 | 1,067 | -47.0% |
| Income from operations before depreciation and amortization (EBITDA) | 578 | 1,055 | -45.2% |
| EBITDA margin before special items (%) | 8.2 | 13.2 | − |
| Depreciation and amortizationa | 459 | 450 | 2.0% |
| Income from operations (EBIT) | 119 | 605 | -80.3% |
| Special items | 12 | –13 | . |
| EBIT before special items | 107 | 618 | -82.7% |
| Investments including acquisitionsb | 765 | 642 | 19.0% |
| Segment cash flow | 503 | –99 | . |
| Assets | 7,496 | 8,038 | -6.7% |
| Return on Capital Employed (ROCE, %) | 1.5 | 7.5 | − |
| Research and development expenses | 150 | 172 | -12.9% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Agricultural Solutions
Million € |
2023 | 2022 | +/- |
| Sales to third parties | 10,092 | 10,280 | -1.8% |
| Intersegment transfers | 36 | 40 | -11.0% |
| Sales including transfers | 10,128 | 10,320 | -1.9% |
| Income from operations before depreciation, amortization and special items | 2,270 | 1,928 | 17.7% |
| Income from operations before depreciation and amortization (EBITDA) | 2,177 | 1,922 | 13.2% |
| EBITDA margin before special items (%) | 22.5 | 18.8 | − |
| Depreciation and amortizationa | 1,046 | 701 | 49.2% |
| Income from operations (EBIT) | 1,131 | 1,221 | -7.4% |
| Special items | –433 | 1 | . |
| EBIT before special items | 1,563 | 1,220 | 28.1% |
| Investments including acquisitionsb | 353 | 414 | -14.7% |
| Segment cash flow | 1,746 | 179 | 875.6% |
| Assets | 16,089 | 17,071 | -5.7% |
| Return on Capital Employed (ROCE, %) | 6.4 | 7.1 | − |
| Research and development expenses | 900 | 944 | -4.6% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Financial data — Othera
| Million € | 2023 | 2022 | +/- |
Sales |
3,220 | 4,368 | -26.3% |
| Income from operations before depreciation, amortization and special items |
–466 | –594 | 21.5% |
Income from operations before depreciation and amortization (EBITDA) |
–626 | –368 | -70.1% |
Depreciation and amortizationb |
153 | 155 | -1.4% |
Income from operations (EBIT) |
–778 | –523 | -48.9% |
Special items |
–164 | 226 | . |
EBIT before special items |
–614 | –749 | 18.0% |
of which costs for cross-divisional corporate research |
–242 | –325 | 25.5% |
costs of corporate headquarters |
–222 | –258 | 14.0% |
other businesses |
83 | –43 | . |
foreign currency results, hedging and other measurement effects |
–29 | 33 | . |
miscellaneous income and expenses |
–204 | –156 | -30.8% |
Investments including acquisitionsc |
195 | 268 | -27.1% |
Assetsd |
14,393 | 16,803 | -14.3% |
Research and development expenses |
356 | 381 | -6.4% |
a Information on the composition of Other can be found in Note 5 to the Consolidated Financial Statements.
b Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
c Additions to property, plant and equipment and intangible assets
d Includes assets of businesses recognized under Other and reconciliation to assets of the BASF Group
| Million € | Sales by location of company |
Sales by location of customer |
||||
|
2023 |
2022 |
+/– |
2023 |
2022 |
+/– |
Europe |
27,631 | 35,821 | -22.9% | 26,022 | 33,922 | -23.3% |
of which Germany |
11,449 | 15,170 | -24.5% | 6,833 | 8,977 | -23.9% |
North America |
19,003 | 24,343 | -21.9% | 18,833 | 23,869 | -21.1% |
| Asia Pacific | 17,142 | 21,309 | -19.6% | 17,520 | 21,823 | -19.7% |
of which Greater China |
9,427 | 11,850 | -20.4% | 9,366 | 11,624 | -19.4% |
South America, Africa, Middle East |
5,126 | 5,854 | -12.4% | 6,527 | 7,713 | -15.4% |
BASF Group |
68,902 | 87,327 | -21.1% | 68,902 | 87,327 | -21.1% |